ArticleMolecular therapy. Methods & clinical development2019

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome.

Fanny Collaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.